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Aim. The work is aimed at confirmation of earlier assumed mechanism of tRNA channeling. Methods. The
methods of band shift assay and Forsters resonance energy transfer were used. Results. The affinities of
mammalian tRNAs for two tissue specific isoforms of elongator factor eEF1A1 and  eEF1A2 were
compared. For the first time we have shown the ability of yeast eEF1A*GDP to form   non-canonical ternary
complex with deacylated tRNAs. The complexation of eukaryotic eEF1A with initiator  tRNA, of both
bacterial and mammalian origin, was also demonstrated. Conclusions. The formation of the non-canonical
complexes of eEF1A*GDP with deacylated tRNAs is common  for higher and lower eukaryotes, which is in
favor of universality of eukaryotic tRNA-channeling. 
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Introduction. The process of protein biosynthesis is
known to be functionally compartmentalized [1], and it
is known that tRNA is never free in the cell and all the
time is bound to some partners [2, 3]. The protein
eEF1A forms a complex with aa-tRNA in a GTP-de-
pendent manner and delivers it to the ribosomal A-site.
In higher eukaryotes eEF1A*GDP is suggested to
accept deacylated tRNA from the ribosomal E-site
delivering it to aaRSes for recharge [1]. 
The formation of eEF1A*GDP*tRNA complexes
was shown for several tRNA species, and KD of the
complexes were calculated [4–6]. It was found that the
affinity of tissue specific isoforms of the factor,
eEF1A1 and eEF1A2, to tRNA is different. KD for the
complexes of eEF1A2 with tRNAs usually is 2–4 fold
lower than that for eEF1A1 [6]. Of interest is a re-
latively high affinity of eEF1A to deacylated tRNAs
(KD £750 nM) in comparison with prokaryotic EF1A
(KD > 2200 nM [7–9]). A role of the tRNA body in the
ternary complex formation was discussed for years
[10–12]. 
It was shown, that the affinity of all elongator
aa-tRNA to prokaryotic EF1A*GTP is similar despite
the different chemical properties of various amino acid
residues [13]. Moreover, miss aminoacylated tRNAs
usually posses higher or lower affinity for EF1A than
normal aa-tRNA [13]. This may be in line with earlier
found selectivity of ribosomes against EF1A*GTP
with aa-tRNA bound tighter or slighter than regular
binding [10]. Thus, the requirement of ribosomes for
the stable thermodynamic conditions of aa-tRNA*
EF1A*GTP complex may explain a possible functional 
role of this compensating mechanism in the selection of 
properly aminoacylated tRNA on ribosome.
The structure of aa-tRNA*EF1A*GTP ternary
complex is known. X-ray crystallography [14, 15] sho-
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wed 1:1 stoichiometry of the ternary complex in which
tRNA interacts with EF1A via amino acid residue at 5'
end and double helix structure of the acceptor and T-
stems. The detailed analysis of the crystallographic
data revealed that EF1A interacts with tRNA pre-
ferably through the saccharophosphate backbone of the 
tRNA and only two amino acid residues of EF1A make
contacts directly with tRNA bases (these nucleosides
are G in 63:51 base pair and C75). The only one
confirmed site of prokaryotic EF1A affinity tuning is
Glu390 (according to Thermus thermophilus EF1A
numeration) which interacts with G in 63:51 base pair
of tRNA T-stem, forms hydrogen bond, resulting in
increasing an overall stability of the complex [14, 15].
Interestingly, in yeasts and plants an adenosine at 64:50 
site in tRNAi
Met is usually modified with O-phos-
phoribosyl group, preventing binding of these tRNAs
to eEF1A. Notably, the initiator tRNA from mammals
does not contain any modifications at 64:50 site. 
Thus, the base pairs in T-stem of tRNA acts as
check points for excluding initiator tRNA from elon-
gation, preventing its participation in yeast and plant
eEF1A*GTP*aa-tRNA complex. We suggest, that the
same base pairs of T-stem may be responsible for
sequestering tRNAs by rabbit eEF1A*GTP.
In analogy with prokaryotic EF1A, in the structure
of eukaryotic eEF1A there is amino acid residue
Asp428 at the same position as Glu390 (according to
the alignment of eEF1A to EF1A [16]). Asp and Glu
residues in proteins are known to form hydrogen bonds
with guanines in RNA structures [17–20]. So, it is plau- 
sible to suggest that Asp of eEF1A contacts guanine
situated at 51:63 base pair of tRNA. Moreover, one can
expect a difference between eEF1A and EF1A in
affinity to tRNA, because Asp residue has shorter side
chain than Glu, and probably will not reach the same
depth in a minor groove of tRNA, resulting in the loss
of contact with G at 63:51 base pair.
In this work the formation of stable complexes of
yeast and rabbit eEF1A*GDP with deacylated tRNAs
in vitro was demonstrated by a band shift assay and
confirmed by a FRET fluorescence technique. The
ability of eEF1A to interact with deacylated initiator
tRNAs has also been checked.
Recently, no interaction of deacylated tRNA with
yeast eEF1A has been found by fluorescence technique 
[21]. Here the formation of yeast non-canonical ternary 
complex eEF1A*GDP*tRNA was re-tested to answer
the question about the universality of such complexes
in higher and lower eukaryotes. 
Materials and Methods. Materials. T4-polynuc-
leotide kinase, T7-RNA polymerase, Calf intestine al-
kaline phosphatase, NTP-set (ATP, CTP, UTP, GTP),
BshNI restriction endonuclease, DEPC-treated water
(«Fermentas», Lithuania); Qiagen Plasmid Midi Kit
(«Qiagen», USA); 1,5-IAEDANS («Invitrogen»,
USA); [14C]-L-Lysine, [14C]-L-Valine, [14C]-L-tyrosi-
ne, [3H]-GDP («GE-Lifescience», UK); [1-14C]-L-me-
thionine («Moravec Biocemicals», USA); Trizma,
GDP, GMP, phosphodiesterase of snake venom PDE I
Type IV from Crotalus athrox venom, BD-cellulose
(«Sigma», USA); b-mercapthoethanol, Glycerol,
NH4Cl, MgCl2, DMF («Merck», Germany); acryl-
amide (double recrystalised), TEMED, PMSF, DTT,
EDTA («Serva» Germany); Filters GF/C, DEAE-
cellulose (DE52), phosphocellulose (P-11), CM-cel-
lulose (CM52) («Whatman», UK); ammonium persul-
phate, Cumassi R-250 («Bio-Rаd», UK); scintillation
fluid OptiPhase «HiSafe» («Sed», USA); N,N-methy-
lenbisacrylamide, Tris, HEPES, Na-dodecylsulphate
(SDS) («Helicon», Russia).
Other reagents were marked «high grade» or «ultra
pure».
tRNA-nucleotidyl transferase was purified from
yeasts as described [22].
The total aaRS preparation from Escherichia coli
[23] and rabbit liver were purified as described [24].
tRNALeu from T. thermophilus was donated by Dr.
O. P. Kovalenko  and Dr. O. I. Gudzera. 
The preparations of eEF1A1 from rabbit liver and
eEF1A2 from rabbit muscles were kindly granted by
Dr. V. F. Shalak  and D. O. Vlasenko  correspondingly.
The eEF1A1 and eEF1A2 activity was verified in
[3H]GDP/GDP exchange reaction according to [25].
Transcription of tRNA3
Lys. We transformed E. co-
li-XL-Blue cells as described [26] with plasmid
pUC18-tRNA3
LysWT, which was designed in previous
work [6], and prepared 200 ml overnight culture at
37 °C. Then the plasmid was purified with Qiagen
Plasmid Midi Kit («Qiagen», USA), and used for
transcription reaction with T7-RNA polymerase. The
plasmid carried the gene of tRNA3
Lys, treatment of the
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plasmid with BshNI endonuclease reduced this gene to
74 coding nucleotides, made it deficient on C75 and
A76 at 3' end. The mixture containing 1X Buffer
(40 mM Tris HCl, pH 7.9, 6 mM MgCl2, 10 mM DTT,
10 mM NaCl, 2 mM Spermidine), 50 mg of plasmid,
NTPs (2 mM each), 50 mg of T7-RNA polymerase and
400 U of RNAsine («Promega», USA). After 2 h of
incubation at 37 °C 50 mg of pyrophosphatase was
added, and reaction was stopped after 4 h of incubation. 
The mixture was separated on 8 % PAAG with 7 M
urea. The band of tRNA was detected under UV
illumination and eluted as described previously [6]
following with an additional step of purification on the
500 ml DEAE column (tRNA loaded in 50 mM
NH4Acetate, 10 mM MgCl2, and 10 mM NaCl, and
eluted in the same buffer with 1 M NaCl). tRNA was
precipitated with 3 volumes of ethanol at –20 °C
overnight. Finally tRNA was dissolved in DEPC-
treated water and the activity was verified in the ami-
noacylation reaction as described [6] (with addition of
tRNA-nucleotidyl transferase, ATP and CTP to add the 
last two nucleotides of tRNA).
Fluorescence labeling of tRNA with 1,5-IAEDANS.
The tRNA3
Lys was labeled with 1,5-IAEDANS as
described [27]. The reaction of thiocytidine (S2C)
incorporation was performed in 20 mM Tris HCl
buffer, pH 8.0, containing 0.5 mM DTT, S2CTP, ATP
and nucleotidyl-tRNA transferase for 1 h at 37 °C, and
than mixture was precipitated with ethanol, the
incorporation of S2C and ATP was verified by a
mobility assay on denaturing 10 % PAAG. 
The alkylation reaction was performed in 100 mM
NaAc buffer, pH 5.2, containing 100 mM NaCl, 10 mM 
MgCl2, 1,5-IAEDANS dissolved in N,N-DMF, for 4 h
at 37 oC in the dark, and tRNA was purified on Se-
phadex G25 microspin columns. The effectivity of la-
beling was determined according to the formula [28]: 
fa = (A336/eIAEDANS) × (MW[tRNA]/C[tRNA];                (1)
the eIAEDANS value is known to be 5700 M
–1cm–1 and the
labeling ratio 0.6257 was calculated. 
Purification of individual tRNAs. The rabbit liver
tRNA purification procedure was described previously
[6]. The tRNA specificity was determined in ami-
noacylation reaction using total aaRS preparation from
rabbit liver. Eukaryotic initiator tRNAi
Met unlike elon-
gator tRNAe
Met can be aminoacylated by the total aaRS
preparation from E. coli, and this was used for the
tRNAi
Met identification.
Finally, tRNA was purified using 8 % PAAG elec-
trophoresis with 7 M Urea. The individual tRNA sam-
ples were treated with phosphodiesterase I for 20 min
and then labeled by 3' end with [a-32P]-ATP using yeast 
tRNA-nucleotidyl transferase as described [29]. 
The sample of tRNAfMet from E. coli was treated
with Calf intestine phosphatase for 2 h at 37 °C fol-
lowing by phenol extraction and the precipitation with
ethanol. The [g-32P] ATP and T4-polynucleotide kinase 
were used to incorporate radioactive label at 5' end of
tRNAi
fMet. Reaction was performed in PNK-Buffer for
1 h at 37 °C. The reaction mixture was loaded onto the
8 % PAAG with 7 M Urea and the radioactive band of
tRNA was identified and eluted as described [6].
Purification of individual tRNAs from commer-
cially available samples of total RNA resulted in lost of
tRNA activity. The structure of yeast tRNAs generally
is similar to the tRNAs from higher eukaryotes, thus we 
used mammalian tRNAs instead of yeast.
Purification of eEF1A from Saccaromyces cere-
visiae. Purification of eEF1A was performed ac-
cording to the modified scheme from [30, 31]. Prepa-
rative amounts of the brewer’s yeast cells were kindly
granted by the Quality Control Laboratory of the «Po-
dil» Brewery Company (Kyiv, Ukraine). Cells were
washed with start buffer (60 mM Tris HCl, pH 7.5,
50 mM NH4Cl, 5 mM MgCl2, 10 % Glycerol, 1 mM
DTT, 0.1 mM EDTA, pH 8.0, and «Complete» in-
hibitor cocktail («Roche», USA), at amounts recom-
mended by the manufacturer, three times and then
destroyed in the orbital centrifuge with glass beads.
Cell debris was removed by centrifugation at 12000 g
for 20 min. The supernatant was loaded on DEAE-
cellulose (DE52, Whatman) pre-equilibrated with
buffer 1 (20 mM Tris HCl, pH 7.5, 25 % Glycerol,
1 mM DTT, 0.1 mM EDTA pH 8.0, and 0.2 mM
Phenylmethylsulfonyl fluoride) with 100 mM KCl.
The unbound material and the wash were mixed with
phosphocellulose (P-11, «Whatman»), pre-equili-
brated with buffer 1, containing 100 mM KCl. The
phosphocellulose slurry was washed with buffer 1,
containing 100 mM KCl, and then with buffer 1
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containing 0.5 M KCl. The released material and wash
were combined and dialyzed overnight against buffer
1, containing 50 mM KCl. The supernatant was applied 
on CM-cellulose column (CM52, carboxymethyl cel-
lulose, Whatman) pre-equilibrated with buffer 1 with
50 mM KCl. The elution was performed with a linear
salt gradient from 50 to 300 mM KCl (ten column volu- 
mes) in buffer 1. The purity of the protein was found to
be approximately 80 % according to SDS-polyac-
rylamide gel electrophoresis. The activity of the factor
was verified in the reaction of [3H]GDP/GDP exchan-
ge [25] and found similar to the activity of eEF1A puri-
fied from rabbit liver and muscles (data not shown).
The Band Shift Assay. The band retardation assays
were carried out as described previously [6].
Fluorescence Spectroscopy. All steady-state
fluorescence measurements were performed with the
Varian Cary Eclipse Fluorescence Spectrophotometer
(Varian Australia Pty Ltd, Australia) using 10 mm ´
 ´ 10 mm quartz cuvettes with a sample volume of
500 ml in the buffer, containing 20 mM Hepes-KOH,
pH 7.5, 100 mM KCl, 10 % Glycerol, 0.1 mM EDTA,
and 100 mM GDP. Tryptophan was excited at 280 nm,
scans ranged from 290 to 540 nm. In all cases, the ex-
perimental parameters were as follows: excitation slit
width of 5 nm, emission slit width of 5 nm, integration
time of 0.1 s, and photomultiplier voltage of 950 V. The 
FRET efficiency was measured by the energy transfer
 
                  E = (1 – (IDA / ID))/fa,                               (2)
where IDA is the fluorescence intensity of the donor in
the presence of the acceptor and ID is the fluorescence
intensity of the donor in the absence of the acceptor
(the fluorescence intensities of the donor and donor-ac- 
ceptor pair were corrected for the impact of the buffer
solution and acceptor itself in the buffer respectively).
The apparent efficiencies were normalized by fa,
the fractional labeling with acceptor, as shown in eq. 1
[32]. The distance R between the donor and the
acceptor was calculated by the Forster equation
                   R = (R0
6/E6 – R0
6)1/6,                           (3)
where the Forster radius R0 is 22 Е for the Trp-
IAEDANS pair [33, 34].
Results. Recently, we have examined the ability of
a number of various deacylated tRNAs to form ternary
complex with two tissue specific isoforms of eEF1A by 
band shift assay [4–6]. Here we used the same tech-
nique for the comparative analysis of the ability of
bacterial, yeast and mammalian elongation factors 1A
to bind deacylated [32P]-labeled tRNAs. tRNAVal,
tRNATyr, tRNALys, tRNAi
Met from rabbit liver, tRNAi
fMet
from E. coli and tRNALeu from T. thermophilus were
used. The apparent KDs of the complexes of tRNA
Val,
tRNATyr and tRNALys with rabbit liver eEF1A1*GDP
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Rabbit liver tRNAVal
2      1     0.5  0.25 0.12 0.06    2     1    0.05 0.25 0.12 0.06    0 mM
eEF1A1                                   eEF1A2
A
Rabbit liver tRNATyr
2      1     0.5  0.25 0.12 0.06    2     1    0.05 0.25 0.12 0.06   0  
eEF1A1                                   eEF1A2
B
mM
Rabbit liver tRNALys
2     1    0.5  0.25 0.12 0.06     2      1    0.05  0.25 0.12 0.06   0  
eEF1A1                                   eEF1A2
C
mM
Fig. 1. The stability test for ternary complexes of tRNAs with
eEF1A1*GDP and eEF1A2*GDP: A – Radioautograph of electro-
phoregram of eEF1A1*GDP*tRNAVal and eEF1A2*GDP*tRNAVal
complexes at eEF1A1/eEF1A2 concentration range from 2 mM to
0.06 mM, in non-denaturing (native) conditions; B – like A but
eEF1A1*GDP*tRNATyr and eEF1A2*GDP*tRNATyr complexes;
C – like A but eEF1A1*GDP*tRNALys and eEF1A2*GDP* tRNALys
complexes
were estimated to be in the range from 0.5 to 1 mM (Fig. 
1, A, B, C). The complexes of the same tRNAs with
eEF1A2 are characterized with KDs in the range of
0.25–0.5 mM. KDs for the complexes of yeast eEF1A
with the same tRNA appears to be in the range of
0.1–0.25 mM (Fig. 2). The experimental data are
summarized in Table.
The formation of an unusual complex of bovine
initiator tRNAi
Met with both isoforms of eEF1A was
demonstrated by us previously [6]. These data con-
firmed the absence of specific antideterminants for
eEF1A in tRNAi structure [36–36]. Here we examined
whether the yeast eEF1A is able to form such complex
with rabbit tRNAi
Met or E. coli tRNAi
fMet. Importantly, it
is known that tRNAi
Met from yeast or plants, containing
A64 O-phosphoribosyl modification, can not interact
with eEF1A [16, 37–39]. We have found that both
mammalian and E. coli initiator tRNA, which contains
no such modification, can bind to the yeast eEF1A with 
a high affinity (Fig. 3). This observation indicates, that
eEF1A by itself cannot discriminate between elongator 
and initiator tRNAs, and the antideterminants residue
in tRNA structure. Noteworthy, EF1A from E. coli did
not bind initiator tRNAi
fMet even at very high concen-
trations (Fig. 4). In agreement with the literature data
[7–9], the elongator tRNALeu from T. thermophilus also
was not bound by EF1A (KD >2 mM) (Fig. 4).
The FRET technique was used to characterize the
non-canonical ternary complexes of yeast eEF1A,
GDP and deacylated tRNA. The transcript tRNA3
Lys
was labeled with 1,5-IAEDANS bound to thiocytidine
introduced at position 75. Near 50 % efficiency of the
Forster’s resonance energy transfer from a Trp residue
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Rabbit liver tRNAVal
2      1    0.5  0.25  0.12  0.06   0         2     1    0.5  0.25  0.12 0.06  0 mM
eEF1A S. cerevisiae
A Rabbit liver tRNATyrB
Rabbit liver tRNALys
2        1     0.5    0.25   0.12   0.06    0 mM
eEF1A S. cerevisiae
C
E. coli tRNAfMet
4     2      1     0.5  0.25 0.12   0       4     2     1     0.5 0.25 0.12  0
eEF1A S. cerevisiae
Rabbit liver tRNAiMet
mM
Fig. 3. Stability test of the complexes eEF1A from S. cerevisiae
with deacylated tRNAfMet from E. coli and tRNAiMet from rabbit
liver 
Fig. 2. The stability test
for eEF1A from S.
cerevisiae ternary
complexes with de-
acylated tRNAs: A –
tRNAVal; B – tRNATyr;
C – tRNALys
tRNA
eEF1A*GDP*tRNA complex KD, mM
Yeast Rabbit liver Rabbit muscle
tRNAVal 0.12 0.75 0.5
tRNATyr 0.25 0.5 0.25
tRNALys 0.25 0.5 0.5
tRNAi
Met 0.25 0.37* 0.25*
tRNAfMet 0.12 Not examined Not examined
*Found in the previous work [6].
Affinity of tRNAs to yeast and rabbit eEF1A
E. coli tRNAfMet
16      8     4      2       1    0.5     0      16     8   4      2      1     0.5  0
eEF1A E. coli
T. thermophilus tRNALeu
mM
Fig. 4. Band Shift Assay of eEF1A from E. coli with tRNAfMet from
E. coli and tRNALeu from T. thermophilus
in yeast eEF1A to 1,5-IAEDANS attached to tRNA3
Lys
was observed (Fig. 5, see inset). According to the X-ray 
structure of the yeast eEF1A complex with truncated
eEF1Ba [40, 41], only Trp78 residue of eEF1A is close 
enough to the hypothetic tRNA binding site to perform
effective energy transfer (Fig. 6). The Forster’s
distance ~2.2 nm was calculated between Trp78 of
eEF1A and 1,5-IAEDANS of tRNA. Thus, formation
of the unusual complex of yeast eEF1A*GDP with
tRNA was confirmed by the FRET technique. The
emission maximum of IAEDANS in water solution is
known to be 490 nm. 
In our experiments, the addition of eEF1A*GDP
caused shift of fluorescence maximum of 1,5-
IAEDANS from 490 to 500 nm, this indicates that
CCA-end of tRNA with attached fluorescent dye turn
into more compact hydrophobic surrounding when
tRNA occurs in the complex with eEF1A. 
Discussion. Similar affinity of yeast and rabbit
eEF1A to deacylated tRNA as well as relatively high
efficiency of FRET from yeast eEF1A to tRNA sug-
gests essential likeness in the interaction of deacylated
tRNA with eEF1A from both higher and lower eu-
karyotes contrary to the authors of [21] we have ma-
naged to find the complexes formation due to the
higher concentration range of 100-1000 nM in
comparison with the previous FRET and stopped flow
kinetics studies.  Moreover, we found the complexes of
yeast eEF1A*GDP with tRNA of different specificity.
The affinity of the ternary complexes is relatively
similar; it is much lower than observed for aa-tRNA but 
enough for the formation of stable complexes.
On the other hand, the mammalian initiator tRNA
does not differ from elongator tRNAs as much as
bacterial and yeast tRNAi
Met does that may explain the
formation of the complex between eEF1A*GDP and
mammalian tRNAi
Met. The 51:63 base pair was
considered to be the only site responsible for the tRNA
affinity to eEF1A. The only one sequence-specific
antideterminant for eEF1A present in eukaryotic
initiator tRNAs is U51:A63. The presence of this base
pair in mutant elongator aa-tRNA decreases their
affinity to eEF1A*GTP*, but not dramatically, close to
the level typical for deacylated elongator tRNAs [16,
37–39]. Some species of elongator tRNA contain G:U
or even A:U in 51:63 site, however, this does not affect
their ability to participate in the elongation [43].
According to the previous data [6] and those presented
here the context of 51:63 base pair is not exclusive site
of tuning the tRNA affinity to eEF1A. It seems the
reason why tRNAi
Met structure allows it to interact with
eEF1A*GDP. 
Thus, in terms of channeling eEF1A can bind ini-
tiator tRNA after its participation in translation initia-
tion step, sequester it and deliver to methionyl-tRNA
synthetase for re-charging.
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Fig. 6. A – Measurement of FRET efficiency from Trp residue of yeast eEF1A to 1,5-IAEDANS covalently bound to the C74 of tRNA3Lys
(solid lines show internal fluorescence of 500 nM eEF1A, dashed lines show decrease in fluorescence intensity in presence of equal amount
of labeled tRNA3Lys); B – a magnified area of 1,5-IAEDANS emission maximum where FRET was observed
It was proposed [5] that non-canonical ternary
complex tRNA*GDP*eEF1A is arranged similar to the 
known structure of ternary complex of aa-tRNA*
GTP*EF1A from bacteria [14, 15]. In the latter
CCA-terminus of tRNA is suggested to interact with a
site in the cleft between I and II domain of eEF1A, and
T-stem to interact with III domain. In this model, tRNA 
interaction with eEF1A is not specific considering the
tRNA sequence, because all of hydrogen bonds are
formed by saccharophosphate backbone of tRNA. The
FRET experiments done here are in favor that CCA end 
of tRNA is apparently located in close proximity to the
cleft between I and II domain of eEF1A. These data
combined with our earlier observation about protection 
of the tRNAPhe T and acceptor stems from RNAse
hydrolysis by eEF1A [4], confirm the assumption, that
tRNA binding to eEF1A is similar to that observed for
prokaryotic analogue. When an amino acid residue is
not present at CCA-terminus, both initiator and
elongator tRNAs can exhibit similar potency for
eEF1A binding. 
In contrast to EF1A from bacteria, that is known to
fall in deep structural rearrangement upon GTP
hydrolysis, leading to the loss of its affinity to tRNA.
The eEF1A conformation is not sensitive for GTP or
GDP binding [40, 41]. This may allow eEF1A*GDP to
interact with deacylated tRNA, protect it against
RNAse hydrolysis, presumably accept free tRNA from
E-site of ribosome and deliver it to aaRSes in the
channeling cycle blocking non-specific recruitment of
tRNAs out of the protein synthesis machinery. The
experiment in vitro, presented here, suggest that
eEF1A may provide tRNA channeling during both
elongation and initiation steps of translation.
Therefore, by two independent methods we have
proved the formation of the non-canonical complexes
between several deacyalated tRNAs and eEF1A*GDP
from eukaryotes contrary to the prokaryotic EF1A*
GDP (or EF1A*GTP), where complexes with deacyla-
ted tRNAs were not observed. This may be explained
by the difference in the structure of prokaryotic EF1A
and eukaryotic eEF1A, latter found to be not so mach
sensitive to GDP/GTP state and aminoacid moiety. The 
formation of the non-canonical complexes of eEF1A*
GDP with deacylated tRNAs seems to be universal for
all eukaryotes. 
The functional role of these complexes was
assumed to serve the channeling of tRNA in the
translation process of higher eukaryotes [4, 5], now we
propose that the channeling of tRNA takes place in the
lower eukaryotes as well.
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Взаємодія різних тРНК з фак то ра ми елон гації транс ляції 1А 
з ни жчих и ви щих еукаріотів 
Ре зю ме
Мета. Підтвер ди ти за про по но ва ний раніше ме ханізм ка на лю -
ван ня тРНК. Ме то ди. Зсув сму ги в поліак ри ламідно му гелі та
Фор стерівське ре зо нан сне пе рене сен ня енергії (FRET). Ре зуль -
та ти. Оцінено спорідненість тРНК ссавців з дво ма тка ни но-
спе цифічни ми ізо фор ма ми фак то раe еEF1A1 та eEF1A2.
Впер ше по ка за но фор му ван ня не ка нонічних потрійних ком -
плексів дріжджо во го eEF1A*GDP з де а циль о ва ни ми тРНК.
Про де мо нстро ва но та кож ком плек со ут во рен ня еу каріот но го
eEF1A з ініціатор ною тРНК ссавців і бак терій. Вис нов ки.
Фор му ван ня не ка нонічних ком плексів eEF1A*GDP з де а циль о -
ва ни ми тРНК є за галь ним для ви щих і ни жчих еу каріотів, що
підтвер джує універ сальність еу каріот но го ка на лю ван ня
тРНК 
Клю чові сло ва: фак тор елон гації, тРНК, транс ляція, ка на -
лю ван ня, елон гація.
П. В. Фу тер ник, Б. С. Нег руц кий, А. В. Ельская 
Вза и мо де йствие раз ных тРНК с фак то ра ми элон га ции 
транс ля ции 1А из низ ших и вы сших эу ка ри о тов 
Ре зю ме
Цель. Под твер дить пред ло жен ный ра нее ме ха низм ка на ли ро -
ва ния тРНК. Ме то ды. Сдвиг по ло сы в по ли ак ри ла мид ном геле
и Фор сте ров ский ре зо нан сный пе ре нос энер гии (FRET). Ре зуль -
та ты. Оце не но сро дство тРНК мле ко пи та ю щих с дву мя тка -
нес пе ци фи чес ки ми изо фор ма ми фак то ра eEF1A1 и eEF1A2.
Впер вые пока за но фор ми ро ва ние не ка нони чес ких трой ных
ком плек сов дрож же во го eEF1A*GDP с де а ци ли ро ван ны ми
тРНК. Так же про де мо нстри ро ва но ком плек со об ра зо ва ние эу -
ка ри от но го eEF1A с ини ци а тор ной тРНК мле ко пи та ю щих и
бактерий. Вы во ды. Фор ми ро ва ние не ка но ни чес ких ком плек сов
eEF1A*GDP с де а ци ли ро ван ны ми тРНК яв ля ет ся об щим для
вы сших и низ ших эу ка ри о тов, что под твер жда ет уни вер саль -
ность эу ка ри от но го ка на ли ро ва ния тРНК.
Клю че вые сло ва: фак тор элон га ции, тРНК, транс ля ция, ка -
на ли ро ва ние, элон га ция.
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